Shu Zheng

zhejiang university school of medicine

H指数:65

被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional characterization of CASP, a CUX1 isoform, reveals its tumor-promoting role in colorectal cancer via TRIM21-mediated signaling

CASP，一种CUX1异构体，的功能特征表明其通过TRIM21介导的信号通路在结直肠癌中发挥促肿瘤作用。

iScience

IF4.1

2026-01-290

OAAI

Immune dysregulation in preeclampsia: integrative analysis of peripheral transcriptomes and placental single-cell land-scapes

子痫前期中的免疫失调：外周转录组与胎盘单细胞景观的整合分析

Frontiers in Immunology

IF5.9

2025-12-010

OAAI

psiTPTE22-HERV functions as a tumor suppressor by inhibiting PI3K/AKT/mTOR/EIF4E signaling

psiTPTE22-HERV通过抑制PI3K/AKT/mTOR/EIF4E信号通路发挥肿瘤抑制功能。

Genes & Diseases

IF9.4

2025-10-310

OAAI

Integrated multiomics analysis of MSI-H colorectal cancer identifies a subtype with poor outcome

MSI-H结直肠癌的整合多组学分析识别出一种预后不良的亚型

Modern Pathology

IF5.5

2025-09-220

PRE

Fermentation Process Optimization of Strawberry Wine Using the 2-Phenylethanol Tolerant Saccharomyces cerevisiae AFRC01 and Comparative Genomic Analysis

使用2-苯乙醇耐受性酿酒酵母AFRC01的草莓酒发酵过程优化及比较基因组分析

Foods 2025, Vol. 14, Page 3043

IF5.1

2025-08-290

Case Report: Surgical timing for Blount's disease: a case report and systematic review

病例报告：Blount's disease的手术时机：一例病例报告和系统综述

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2025-04-090

HOXC6 promotes the metastasis of MSI-H CRC by interacting with M2 macrophages and inducing effector T cell exhaustion

CELL COMMUNICATION AND SIGNALING

IF8.9

2025-04-040

OAAI

Joint optimal PMU and DULR placement in distribution network considering fault reconstruction and state estimation accuracy (vol 162, 110320, 2024)

INTERNATIONAL JOURNAL OF ELECTRICAL POWER & ENERGY SYSTEMS

IF5

2025-03-010

OAAI

Joint optimal PMU and DULR placement in distribution network considering fault reconstruction and state estimation accuracy

INTERNATIONAL JOURNAL OF ELECTRICAL POWER & ENERGY SYSTEMS

IF5

2024-11-010

OAAI

Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics

CELL DISCOVERY

IF12.5

2024-08-130

OAAI

Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Nonadherence to Referral Colonoscopy After Positive Fecal Immunochemical Test Results Increases the Risk of Distal Colorectal Cancer Mortality

GASTROENTEROLOGY

IF25.1

2023-12-014

Pan-cancer analysis of DNA epigenetic modifications by hydrophilic interaction liquid chromatography-tandem mass spectrometry

CHINESE CHEMICAL LETTERS

IF8.9

2023-07-0112

PRE

The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2023-06-062

PRE

Surufatinib plus doublet (FOLFOX/FOLFIRI) or triplet (FOLFOXIRI) chemotherapy as second-line therapy in metastatic colorectal cancer (mCRC): First-stage results of a randomized, open-label phase II trial

ANNALS OF ONCOLOGY

IF65.4

2023-06-010

FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients

CANCER LETTERS

IF10.1

2023-05-013

Molecular characterization of colorectal mucinous adenocarcinoma and adenocarcinoma, not otherwise specified, identified by multiomic data analysis

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2023-04-052

OAAI

Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2762

OAAI

Automatic Scoring Method for Tumor IHC Images Based on Deep Learning and Its Application on P53 Protein

IEEE ACCESS

IF3.6

2023-01-012

N4BP3 promotes breast cancer metastasis via NEDD4-mediated E-cadherin ubiquitination and degradation

CANCER LETTERS

IF10.1

2022-12-0112

PRE

Shu Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向